Topical imiquimod treatment of human papillomavirus in a patient with human immunodeficiency virus [1]

Acta Dermato-Venereologica

Volumn 81, Issue 4, 2001, Pages 301-302

  Gilbert, J ^a   Drehs, M M ^a   Weinberg, J M ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; CASE REPORT; CONDYLOMA; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LETTER; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINOQUINOLINES; ANUS DISEASES; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME; WARTS;

EID: 0034776324     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550152572994     Document Type: Letter

References (9)

1. Self-administered topical 5% imiquimod cream for external anogenital wart
2. Treatment of genital warts with an immune-response modifier (imiquimod)
3. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
4. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
5. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%
6. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum
7. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals
8. A randomized, controlled, safety study using imiquimod for the topical treatment of anogential warts in HIV-infected patients
9. Immunomodulatory therapy in the management of viral infections in patients with HIV infection